Spartina Biotechnologies

RNA-based medical technologies rocketed to prominence with the application of mRNA for vaccines against Covid-19. Gene therapy applications and RNAi molecules for suppression of viruses could completely change the pharmaceutical landscape in the same way as the discovery of Penicillin for the treatment of bacterial infections.  However, since RNA molecules are highly unstable; a safe, efficient, and precise delivery of therapeutic payloads to targeted cells in human bodies is needed.

Spartina Biotechnologies solves this problem with its SIREN™ platform for precision RNA delivery to most or all organs or cell types. By precisely controlling the expression of a single gene, RNA therapeutics focus laser-like on viruses and other drug targets, while minimizing or eliminating unwanted side effects: Precise. Efficient. Safe. 

Because humanity’s greatest medical challenge today is COVID-19, our first target is the SARS-CoV-2 virus. However, SIREN may also be used to treat numerous human diseases by silencing deleterious genes or providing functional mRNAs to replace defective ones, thereby disrupting the RNA therapeutics industry. Our mission is to establish SIREN as the go-to delivery system for pharmaceuticals.